Rheumatoid arthritis caused by non-tuberculous mycobacteria infection

被引:0
|
作者
Takaoka, Hirokazu [1 ,3 ]
Shimomura, Taizo [2 ]
Suzushima, Hitoshi [2 ]
机构
[1] Kumamoto Shinto Gen Hosp, Sect Internal Med & Rheumatol, Kumamoto, Japan
[2] Kumamoto Shinto Gen Hosp, Div Hematol, Kumamoto, Japan
[3] Kumamoto Shinto Gen Hosp, Sect Internal Med & Rheumatol, 3-2-65 Ooe, Chuo-ku, Kumamoto 8628655, Japan
关键词
RA; Mycobacterium marinum; IL-6; tocilizumab; MSUS; INNATE;
D O I
10.1093/mrcr/rxac001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 72-year-old Japanese woman had right digital flexor tenosynovitis with a non-tuberculous mycobacteria (NTM) infection, which was identified as Mycobacterium marinum in culture. She had been treated at another hospital with clarithromycin, rifampicin, and ethambutol for the non-tuberculous tenosynovitis. However, the swelling of her right hand worsened, and 5 months later, her left hand swelled and she exhibited symmetrical arthritis. Blood tests detected elevated serum C-reactive protein and rheumatoid factor positivity. Although rheumatoid arthritis (RA) was suspected and corticosteroid treatment was started, she came to our hospital because of the insufficient treatment effect. Musculoskeletal ultrasonography showed intra-articular and peritendinous power Doppler signal-positive symmetrical synovitis. A contrast-enhanced magnetic resonance imaging (MRI) evaluation of the left hand without NTM tenosynovitis revealed findings of inflammatory synovitis accompanied by bone marrow oedema. We diagnosed RA and started treatment with weekly low-dose methotrexate pulses and 2 weeks of tocilizumab administration; her symptoms then disappeared within 2 months. This is a rare case of RA manifested with NTM-associated arthritis.
引用
收藏
页码:1 / 4
页数:4
相关论文
共 50 条
  • [41] Cancer risk in patients with rheumatoid arthritis treated with non-TNFi bDMARDs: A nationwide register-based Danish cohort study
    Westermann, R.
    Cordtz, R.
    Duch, K.
    Mellemkjaer, L.
    Hetland, M.
    Dreyer, L.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2023, 52 : 13 - 14
  • [42] Effectiveness and safety of tocilizumab in monotherapy in biologic-naive and non-naive patients with rheumatoid arthritis in a real-world setting
    Marsal Barril, Sara
    Auxiliadora Martin-Martinez, Ma
    Javier Blanco-Garcia, Francisco
    Fernandez-Nebro, Antonio
    Garcia de Vicuna, Rosario
    Tornero-Molina, Jesus
    Sanchez-Alonso, Fernando
    Novella-Navarro, Marta
    Escudero-Contreras, Alejandro
    Jose Alegre-Sancho, Juan
    Urruticoechea-Arana, Ana
    Sagrario Bustabad-Reyes, Maria
    Trenor-Larraz, Pilar
    Perez-Sandoval, Trinidad
    Isabel Tevar-Sanchez, Maria
    Sanchez-Costa, Jesus T.
    Raya-Alvarez, Enrique
    REUMATOLOGIA CLINICA, 2022, 18 (10): : 567 - 573
  • [43] Prosthetic joint infection after total hip or knee arthroplasty in rheumatoid arthritis patients treated with nonbiologic and biologic disease-modifying antirheumatic drugs
    Momohara, Shigeki
    Kawakami, Kosei
    Iwamoto, Takuji
    Yano, Koichiro
    Sakuma, Yu
    Hiroshima, Ryo
    Imamura, Hitoshi
    Masuda, Ikuko
    Tokita, Asami
    Ikari, Katsunori
    MODERN RHEUMATOLOGY, 2011, 21 (05) : 469 - 475
  • [44] Usefulness and limitations of QuantiFERON-TB Gold in Japanese rheumatoid arthritis patients: proposal to decrease the lower cutoff level for assessing latent tuberculosis infection
    Maeda, Tomoyo
    Banno, Shogo
    Maeda, Shinji
    Naniwa, Taio
    Hayami, Yoshihito
    Watanabe, Maiko
    Itoh, Rei
    Sato, Shigeki
    Ueda, Ryuzo
    MODERN RHEUMATOLOGY, 2010, 20 (01) : 18 - 23
  • [45] Safety and effectiveness of abatacept in Japanese non-elderly and elderly patients with rheumatoid arthritis in an all-cases post-marketing surveillance
    Harigai, Masayoshi
    Ishiguro, Naoki
    Inokuma, Shigeko
    Mimori, Tsuneyo
    Ryu, Junnosuke
    Takei, Syuji
    Takeuchi, Tsutomu
    Tanaka, Yoshiya
    Takasaki, Yoshinari
    Yamanaka, Hisashi
    Yoshizawa, Yuri
    Chineni, Ichino
    Nakao, Toru
    Koike, Takao
    MODERN RHEUMATOLOGY, 2019, 29 (05) : 747 - 755
  • [46] Modified- versus immediate-release tofacitinib in Japanese rheumatoid arthritis patients: a randomized, phase III, non-inferiority study
    Tanaka, Yoshiya
    Sugiyama, Naonobu
    Toyoizumi, Shigeyuki
    Lukic, Tatjana
    Lamba, Manisha
    Zhang, Richard
    Chen, Connie
    Stock, Thomas
    Valdez, Hernan
    Mojcik, Christopher
    Fan, Haiyun
    Deng, Chenhui
    Yuasa, Hirotoshi
    RHEUMATOLOGY, 2019, 58 (01) : 70 - 79
  • [47] Recurrent Scedosporium apiospermum Cutaneous Infection in a Patient with Rheumatoid Arthritis: The Potent Role of IL-6 Signaling Pathway Blockade: A Case-Based Review
    Pieta, Antigone
    Venetsanopoulou, Aliki I.
    Kittas, Christos
    Christaki, Eirini
    Voulgari, Paraskevi V.
    JOURNAL OF FUNGI, 2023, 9 (06)
  • [48] Cod liver oil (n-3 fatty acids) as an non-steroidal anti-inflammatory drug sparing agent in rheumatoid arthritis
    Galarraga, B.
    Ho, M.
    Youssef, H. M.
    Hill, A.
    McMahon, H.
    Hall, C.
    Ogston, S.
    Nuki, G.
    Belch, J. J. F.
    RHEUMATOLOGY, 2008, 47 (05) : 665 - 669
  • [49] Tocilizumab Patterns of Use, Effectiveness, and Safety in Patients with Rheumatoid Arthritis: Final Results from a Set of Multi-National Non-Interventional Studies
    Haraoui, Boulos
    Casado, Gustavo
    Czirjak, Laszlo
    Taylor, Andrew
    Dong, Lingli
    Button, Peter
    Luder, Yves
    Caporali, Roberto
    RHEUMATOLOGY AND THERAPY, 2019, 6 (02) : 231 - 243
  • [50] Sarilumab monotherapy or in combination with non-methotrexate disease-modifying antirheumatic drugs in active rheumatoid arthritis: A Japan phase 3 trial (HARUKA)
    Kameda, Hideto
    Wada, Kazuteru
    Takahashi, Yoshinori
    Hagino, Owen
    van Hoogstraten, Hubert
    Graham, Neil
    Tanaka, Yoshiya
    MODERN RHEUMATOLOGY, 2020, 30 (02) : 239 - 248